Those determined to outshine the market strategically focus on the selection of individual stocks. Well-chosen stocks have the potential to substantially boost your wealth.
QuidelOrtho Corporation (NASDAQ: QDEL) closed the day trading at $38.71 down -3.95% from the previous closing price of $40.30. In other words, the price has decreased by -$3.95 from its previous closing price. On the day, 0.75 million shares were traded. QDEL stock price reached its highest trading level at $40.35 during the session, while it also had its lowest trading level at $38.67.
Ratios:
For a better understanding of QDEL, let’s look at its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 15.47 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 36.50. For the most recent quarter (mrq), Quick Ratio is recorded 0.88 and its Current Ratio is at 1.57. In the meantime, Its Debt-to-Equity ratio is 0.52 whereas as Long-Term Debt/Eq ratio is at 0.49.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, UBS on March 04, 2024, Downgraded its rating to Sell and sets its target price to $42 from $70 previously.
On February 14, 2024, JP Morgan Downgraded its rating to Underweight which previously was Neutral and also lowered its target price recommendation from $66 to $37.
Citigroup Downgraded its Buy to Neutral on December 11, 2023, whereas the target price for the stock was revised from $95 to $72.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Feb 23 ’24 when Busky Joseph M bought 2,150 shares for $46.35 per share. The transaction valued at 99,663 led to the insider holds 2,150 shares of the business.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, QDEL now has a Market Capitalization of 2588874496 and an Enterprise Value of 5041243648. For the stock, the TTM Price-to-Sale (P/S) ratio is 0.86 while its Price-to-Book (P/B) ratio in mrq is 0.52. Its current Enterprise Value per Revenue stands at 1.682 whereas that against EBITDA is 6.848.
Stock Price History:
The Beta on a monthly basis for QDEL is 0.17, which has changed by -0.567824 over the last 52 weeks, in comparison to a change of 0.2160933 over the same period for the S&P500. Over the past 52 weeks, QDEL has reached a high of $95.02, while it has fallen to a 52-week low of $39.86. The 50-Day Moving Average of the stock is -20.30%, while the 200-Day Moving Average is calculated to be -42.43%.
Shares Statistics:
Over the past 3-months, QDEL traded about 1.08M shares per day on average, while over the past 10 days, QDEL traded about 764850 shares per day. A total of 66.70M shares are outstanding, with a floating share count of 48.11M. Insiders hold about 28.03% of the company’s shares, while institutions hold 80.40% stake in the company. Shares short for QDEL as of 1711584000 were 2250916 with a Short Ratio of 2.08, compared to 1709164800 on 2366482. Therefore, it implies a Short% of Shares Outstanding of 2250916 and a Short% of Float of 4.9399999999999995.
Earnings Estimates
The dynamic stock of QuidelOrtho Corporation (QDEL) is currently being evaluated by a team of 6 analysts, each contributing to its current rating.On average, analysts expect EPS of $0.58 for the current quarter, with a high estimate of $0.74 and a low estimate of $0.36, while EPS last year was $1.8. The consensus estimate for the next quarter is $0.05, with high estimates of $0.21 and low estimates of -$0.25.
Analysts are recommending an EPS of between $2.77 and $1.8 for the fiscal current year, implying an average EPS of $2.46. EPS for the following year is $3.92, with 6 analysts recommending between $4.87 and $3.25.
Revenue Estimates
6 analysts predict $703.14M in revenue for the current quarter. It ranges from a high estimate of $734.42M to a low estimate of $681.9M. As of the current estimate, QuidelOrtho Corporation’s year-ago sales were $794.05M, an estimated decrease of -11.40% from the year-ago figure. For the next quarter, 6 analysts are estimating revenue of $645.74M, an increase of 5.00% over than the figure of -$11.40% in the same quarter last year. There is a high estimate of $661M for the next quarter, whereas the lowest estimate is $632.17M.
A total of 6 analysts have provided revenue estimates for QDEL’s current fiscal year. The highest revenue estimate was $2.86B, while the lowest revenue estimate was $2.72B, resulting in an average revenue estimate of $2.79B. In the same quarter a year ago, actual revenue was $3B, down -6.80% from the average estimate. Based on 6 analysts’ estimates, the company’s revenue will be $2.91B in the next fiscal year. The high estimate is $2.99B and the low estimate is $2.75B. The average revenue growth estimate for next year is up 4.30% from the average revenue estimate for this year.
